Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Perlin

Showing results (141-150 of 284) with videos related to

Pageof 29
Sort By:
Msphere|September 2, 2017
An Aptamer-Based Biosensor for the Azole Class of Antifungal DrugsGregory R Wiedman, Yanan Zhao, Arkady Mustaev, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2012
Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistanceSantosh K Katiyar, Ana Alastruey-Izquierdo, Kelley R Healey, et al.
The Journal of Antimicrobial Chemotherapy|May 21, 2019
Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus speciesJoseph Meletiadis, Maria Siopi, Lamprini Kanioura, et al.
Medical Mycology|January 26, 2018
Applying host disease status biomarkers to therapeutic response monitoring in invasive aspergillosis patientsYanan Zhao, Yoji Nagasaki, Padmaja Paderu, et al.
Journal of Fungi (Basel, Switzerland)|August 23, 2020
Differential Regulation of Echinocandin Targets Fks1 and Fks2 in <i>Candida glabrata</i> by the Post-Transcriptional Regulator Ssd1Kelley R Healey, Padmaja Paderu, Xin Hou, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
Host biomarkers of invasive pulmonary aspergillosis to monitor therapeutic responseMila Krel, Vidmantas Petraitis, Ruta Petraitiene, et al.
Infection and Drug Resistance|July 16, 2019
Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against <i>Candida albicans</i> and <i>Candida dubliniensis</i>Eszter Prépost, Zoltán Tóth, David S Perlin, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2014
Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyrJanet F Staab, Dionysios Neofytos, Peter Rhee, et al.
The Journal of Infectious Diseases|July 28, 2011
Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistanceRonen Ben-Ami, Guillermo Garcia-Effron, Russell E Lewis, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2019
Penetration of Ibrexafungerp (Formerly SCY-078) at the Site of Infection in an Intra-abdominal Candidiasis Mouse ModelAnnie Lee, Brendan Prideaux, Matthew Zimmerman, et al.
Pageof 29

Showing results (141-150 of 284) with videos related to

Sort By:
Pageof 29
Msphere|September 2, 2017
An Aptamer-Based Biosensor for the Azole Class of Antifungal DrugsGregory R Wiedman, Yanan Zhao, Arkady Mustaev, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2012
Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistanceSantosh K Katiyar, Ana Alastruey-Izquierdo, Kelley R Healey, et al.
The Journal of Antimicrobial Chemotherapy|May 21, 2019
Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus speciesJoseph Meletiadis, Maria Siopi, Lamprini Kanioura, et al.
Medical Mycology|January 26, 2018
Applying host disease status biomarkers to therapeutic response monitoring in invasive aspergillosis patientsYanan Zhao, Yoji Nagasaki, Padmaja Paderu, et al.
Journal of Fungi (Basel, Switzerland)|August 23, 2020
Differential Regulation of Echinocandin Targets Fks1 and Fks2 in <i>Candida glabrata</i> by the Post-Transcriptional Regulator Ssd1Kelley R Healey, Padmaja Paderu, Xin Hou, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
Host biomarkers of invasive pulmonary aspergillosis to monitor therapeutic responseMila Krel, Vidmantas Petraitis, Ruta Petraitiene, et al.
Infection and Drug Resistance|July 16, 2019
Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against <i>Candida albicans</i> and <i>Candida dubliniensis</i>Eszter Prépost, Zoltán Tóth, David S Perlin, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2014
Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyrJanet F Staab, Dionysios Neofytos, Peter Rhee, et al.
The Journal of Infectious Diseases|July 28, 2011
Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistanceRonen Ben-Ami, Guillermo Garcia-Effron, Russell E Lewis, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2019
Penetration of Ibrexafungerp (Formerly SCY-078) at the Site of Infection in an Intra-abdominal Candidiasis Mouse ModelAnnie Lee, Brendan Prideaux, Matthew Zimmerman, et al.
Pageof 29